Embrex® BioDevices from Zoetis launched the world’s first commercial in ovo vaccination device more than 20 years ago and today, the Embrex Inovoject® System remains the industry standard for in ovo technology.
Hatcheries large and small are switching to in ovo vaccination to enhance efficiency and bird performance, but not all devices offer the same level of quality, design and support.
With a working capacity of 12,000 to 20,000 eggs per hour, the new Inovoject® M System, an Embrex® BioDevice from Zoetis, can help revolutionize automation in the hatchery.
